Results 221 to 230 of about 717,750 (291)
Leveraging Digital Twins for Stratification of Patients with Breast Cancer and Treatment Optimization in Geriatric Oncology: Multivariate Clustering Analysis. [PDF]
Heudel P, Ahmed M, Renard F, Attye A.
europepmc +1 more source
ABSTRACT Background Elder abuse (EA) is a serious public health concern that is dramatically under‐documented in electronic health records (EHRs). Although structured EHR markers for EA are commonly used in research to identify EA cases in large cohorts due to their accessibility, their validity for capturing clinical EA concerns is unknown ...
Joseph Shin +5 more
wiley +1 more source
Data, Models, and Visuals: How Data Science Methods Can Augment (Geriatric) Oncology Research. [PDF]
Ramsdale E, Mohile S.
europepmc +1 more source
ABSTRACT Introduction Opioids and benzodiazepines (BZDs) are commonly prescribed for managing pain, anxiety, and sleep‐related problems following a hip fracture. Both opioids and BZDs carry risks of persistent dependence, falls, and mortality with long‐term use. Despite these risks, Canada lacks standardized prescribing guidelines for older adults with
Anum Ali +7 more
wiley +1 more source
Perspectives on prehabilitation for older adults with cancer: A report from the International Society of Geriatric Oncology (SIOG) rehabilitation group. [PDF]
Papadopoulos E +12 more
europepmc +1 more source
ABSTRACT Background Elder abuse and neglect (EAN) can lead to severe consequences among victims. However, older adults are often reluctant to seek help. This study explored the efficacy of using motivational interviewing (MI), a technique used to resolve ambivalence about behavioral change by strengthening one's motivation, in reducing subsequent EAN ...
Elsie Yan +5 more
wiley +1 more source
Big Data for Geriatric Oncology Research. [PDF]
Duchesneau ED +4 more
europepmc +1 more source
ABSTRACT Background Falls are the leading cause of injury in older adults. Sedative‐hypnotic use is a known risk factor, but their use for insomnia continues to be common. Dual orexin receptor antagonists (DORAs) are a new, potentially safer class of medications for insomnia.
Arianna Paolone +5 more
wiley +1 more source

